NBD peptide / NF-κB blocker (cell permeable)



ALX-163-011	0	228.00 USD

ALX-163-011-1	1 Vial	239.00 USD

For increased cell permeability the peptide was covalently linked to the 10 aa recognized by the TAT transporter.

Product Specification

Alternative Name:	NEMO-binding domain peptide

Concentration:	10mM

Formula:	C₁₂₁H₂₀₂N₄₈O₃₂

MW:	2841.2

Quantity:	50µl

Purity:	≥95% (HPLC)

Sequence:	GRKKRRQRRR-GG-TALDWSWLQTE-amide

Formulation:	Liquid. In sterile PBS.

Short Term Storage:	-20°C

Long Term Storage:	-80°C

Handling:	After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Protect from moisture. Keep on ice at all times.

Product Literature References

Disruption of IKK-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to HDAC inhibitors: Y. Dai, et al.; J. Biol. Chem. 286, 34036 (2011), Abstract;

Improvement of cardiac contractile function by peptide-based inhibition of NF-kappaB in the utrophin/dystrophin-deficient murine model of muscular dystrophy: D.A. Delfin, et al.; J. Transl. Med. 9, 68 (2011), Abstract; Full Text

Selective inhibition of NF-kappaB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo: E. Jimi, et al.; Nature Med. 10, 617 (2004), Abstract;

Characterization of the Ikappa B-kinase NEMO binding domain: M.J. May, et al.; J. Biol. Chem. 277, 45992 (2002), Abstract;

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex: M.J. May, et al.; Science 289, 1550 (2000), Abstract;